ClinicalTrials.gg
Enrolling by invitationNCT07345351LiPi-TMDUpdated Jul 1, 2026

Lifestyle Counseling vs. Clinical Pilates in Women With Temporomandibular Disorders

An interventional study of Life Counselling and Clinical Pilates in Counseling, Health Counseling and Behavior Therapy, sponsored by Mustafa Kemal University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-01.

Sponsored by Mustafa Kemal University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jul 2025, registered Dec 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 151 studies in Temporomandibular Joint Disorders with a site in Turkey — 27 open to participants now, 28 under way, none of them phase 3. Temporomandibular Joint Disorders · Turkey.

Planned enrollment
19th of 81
62 · median 45
Started
2025
with 20 others
No phase
77 of 151
13 open now
Primary completion
2025-10
later than 17 of 27 live
Registered
122nd of 151
by date

Among the 151 studies in Temporomandibular Joint Disorders with a site in Turkey, this one is the 19th largest by planned enrollment of the 81 interventional ones that give a count, is one of 21 that started in 2025, is one of 77 with no phase, reaches primary completion later than 17 of the 27 other live ones, and was the 122nd registered.

Temporomandibular Joint Disorders

593 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.

Browse Temporomandibular Joint Disorders studies →

Open to participants now

27 of the 151 studies in Temporomandibular Joint Disorders with a site in Turkey are open now. Recruiting first, the newest first:

21 more — sign in →

All 27 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 76 Temporomandibular Joint Disorders studies recruiting now, 26 (34%) set no upper age limit and 46 (61%) stop at 75 or younger; 7 take children under 18; 23 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 151 studies in Temporomandibular Joint Disorders with a site in Turkey, or all of them as a file.
02

Study summary

The goal of this clinical trial is to evaluate the effectiveness of lifestyle counseling alone compared to lifestyle counseling combined with Clinical Pilates in women with temporomandibular disorders (TMD). The study also aims to examine the effects of these interventions on pain, jaw function, posture, oral behaviors, psychological status, sleep quality, and quality of life.

The main questions this study aims to answer are:

Does adding Clinical Pilates to lifestyle counseling reduce pain levels in women with TMD more than lifestyle counseling alone?

Does the combined intervention improve jaw function, head posture, and oral behaviors?

What are the effects of these interventions on anxiety, sleep quality, and quality of life?

Researchers will compare lifestyle counseling alone with lifestyle counseling combined with a supervised Clinical Pilates program to determine whether the addition of Clinical Pilates provides greater clinical and psychosocial benefits.

Participants will be randomly assigned to one of two groups:

  • Receive lifestyle counseling only (control group), or
  • Participate in a supervised Clinical Pilates program twice weekly for 8 weeks in addition to lifestyle counseling (intervention group)

Undergo assessments at baseline (before any intervention) and after completion of the interventions.

Outcome measures will include assessments of pain, jaw function, posture, oral behaviors, psychological status, sleep quality, and quality of life.

Read the detailed description

This study is a randomized controlled experimental trial designed, which investigates the effectiveness of Clinical Pilates when added to lifestyle counseling, aims to contribute to the literature by evaluating its potential role in the treatment planning of women with TMD. Within the scope of this research, the therapeutic effects of Clinical Pilates will be examined.

The study will include agree to participate voluntarily, and meet the study criteria.

Inclusion criteria:

  • Female participants aged between 18 and 45 years
  • Diagnosed with temporomandibular disorder (according to DC/TMD diagnostic criteria)
  • Experiencing TMD-related complaints for at least the past 3 months
  • No prior experience with Pilates or lifestyle counseling
  • No contraindications to exercise
  • Diagnosed with muscle-related TMD

Exclusion Criteria:

  • Presence of rheumatologic diseases
  • Neurological disorders
  • Pregnancy
  • History of head or neck trauma
  • Diagnosis of joint-related TMD (with or without reduction)

Participants will be randomly assigned into two groups:

  • Group 1 (Control Group): Participants will receive lifestyle counseling only.
  • Group 2 (Intervention Group): In addition to lifestyle counseling, participants will take part in a Clinical Pilates exercise program twice a week for a total duration of 8 weeks.

To evaluate the effects of the interventions, pre and post-treatment assessments will be conducted using the following outcome measures:

  • Visual Analog Scale (VAS) and Graded Chronic Pain Scale Version 2.0 (GCPS v2.0) for pain assessment,
  • Jaw Functional Limitation Scale-20 (JFLS-20) and Maximum Mouth Opening (MMO) for assessing jaw function,
  • Craniovertebral Angle Measurement for evaluating head posture,
  • Oral Behavior Checklist (OBC) for assessing oral parafunctions and bruxism,
  • Generalized Anxiety Disorder-7 (GAD-7) for psychological status,
  • Patient Health Questionnaire-15 (PHQ-15) for quality of life,
  • Pittsburgh Sleep Quality Index (PSQI) for sleep quality.

Treatment Program Lifestyle counseling will be delivered as a structured program focusing on stress management, sleep hygiene, oral habits, and nutritional behaviors. Clinical Pilates exercises will be tailored to each participant's symptoms and supervised by an experienced physiotherapist. It will be elaborated during the reporting phase of the study and written into the article.

Sample size The sample size is a critical component in the study, and its consideration is essential for the interpretation of the results.

The sample size of the study will be determined using the GPower 3.1.9 software (GPower, Universität Düsseldorf, Germany) with a statistical power of 85% and a type I error rate of 5%. As there is no existing study with an effect size that precisely matches the current research design, the effect size obtained from a pilot study will be used, and a post-hoc power analysis will be conducted to finalize the sample size.

Statistical Analysis Descriptive statistics are reported as mean and standard deviation or median and mode. Categorical variables are defined with numbers and percentages. The normality assumption is tested using the Shapiro-Wilks test and graphs (hygtogram, QQ plot, etc.). When comparing two groups, the independent groups t-test is used if the assumptions are met, and the Mann-Whitney U test is used if the assumptions are not met. Two-way analysis of variance for repeated measures is used when the assumptions are met, and Friedman's test is used when the assumptions are not met. Chi-squared tests will be used to determine whether there is a significant difference between categorical variables. Analyses will be performed using IBM SPSS v.21 and the significance level will be set at p\<0.05.

03

Conditions studied

  • Counseling
  • Health Counseling
  • Behavior Therapy

Keywords

  • Temporomandibular Disorders
  • Lifestyle Counseling
  • Clinical Pilates
  • Women&#39;s Health
  • Jaw Function
  • Functional Limitation
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18-45
  • Diagnosed with TMD (according to DC/TMD diagnostic criteria)
  • Experiencing TMD symptoms for the past 3 months
  • Have not previously received Pilates or lifestyle counseling
  • Without any condition preventing exercise
  • Diagnosed with muscle-related TMD

Exclusion criteria

Exclusion Criteria:

  • Rheumatological diseases
  • Neurological disorders
  • Pregnancy
  • History of head or neck trauma
  • Diagnosed with joint-related TMD (with or without reduction)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
62 participants (estimated)

Study arms

  • Active comparator
    Arm 1: Life Counselling

    Behavioral: Life Counselling

  • Experimental
    Arm 2: Life Counselling + Clinical Pilates

    Behavioral: Life Counselling · Behavioral: Clinical Pilates

Interventions

  • BehavioralLife Counselling

    Participants receive individualized lifestyle counseling focused on stress management, physical activity, and sleep hygiene. Counseling sessions are conducted weekly for 8 weeks, delivered by a trained healthcare professional. The aim is to improve overall health behaviors related to temporomandibular disorder symptoms.

  • BehavioralClinical Pilates

    Participants receive the same lifestyle counseling described above, combined with supervised clinical Pilates sessions. Pilates exercises focus on strengthening the core and improving posture and jaw function, conducted twice weekly for 8 weeks.

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale (VAS)

    Participants will be asked to mark their pain on a line ranging from 0 (no pain) to 10 (unbearable pain). Pain will be measured at rest and as palpation-induced pain (before and after palpation).

    Time frame: Each participant in the group will be evaluated twice. The first assessment will be conducted at the very beginning of the study before any intervention, and the second assessment will be performed after the interventions have been completed.

  2. Graded Chronic Pain Scale Version 2.0

    The scale provides a simple, practical, and versatile assessment and is included in the DC/TMD diagnostic criteria. It consists of 8 questions: 3 questions assess pain intensity, 4 questions assess pain-related disability, and 1 question determines the number of painful days. For all questions except the 1st and 5th, participants are asked to rate their pain on a scale from 0 ("no pain") to 10 ("worst pain imaginable").

    Time frame: Each participant in the group will be evaluated twice. The first assessment will be conducted at the very beginning of the study before any intervention, and the second assessment will be performed after the interventions have been completed.

  3. Jaw Functional Limitation Scale-20

    This is the most widely used self-report questionnaire for assessing jaw functional limitation in TMD. It is included among the recommended measures in the DC/TMD. The scale has three subscales evaluating masticatory function, jaw movements, and social/functional impact. It is scored using a 0-10 Likert scale. The Turkish version has proven reliability and validity (Yıldız, Kocaman, \& Bingöl, 2024).

    Time frame: Each participant in the group will be evaluated twice. The first assessment will be conducted at the very beginning of the study before any intervention, and the second assessment will be performed after the interventions have been completed.

  4. Maximum Mouth Opening

    This is one of the objective indicators of functional limitation. A normal value is considered to be ≥40 mm. Participants will be asked to open their mouth as wide as possible, and the measurement will be taken using a caliper.

    Time frame: Each participant in the group will be evaluated twice. The first assessment will be conducted at the very beginning of the study before any intervention, and the second assessment will be performed after the interventions have been completed.

  5. Craniovertebral Angle Measurement

    This is a simple and clinically meaningful postural assessment method that provides information about head posture by measuring the forward position of the head. The angle between the line connecting the tragus (the prominence in front of the ear) and the C7 spinous process (lower part of the neck) and the horizontal plane is measured. A normal value is considered ≥48°. Values less than 48° are recorded as forward head posture (head anterior tilt) (Shaghayeghfard et al., 2016).

    Time frame: Each participant in the group will be evaluated twice. The first assessment will be conducted at the very beginning of the study before any intervention, and the second assessment will be performed after the interventions have been completed.

  6. Oral Habits Checklist

    Recommended in the DC/TMD protocol, this checklist is used to assess sleep and daytime bruxism as well as other parafunctional habits (e.g., pencil biting, nail biting) (Ohrbach \& Dworkin, 2017).

    Time frame: Each participant in the group will be evaluated twice. The first assessment will be conducted at the very beginning of the study before any intervention, and the second assessment will be performed after the interventions have been completed.

  7. Generalized Anxiety Disorder-7 Questionnaire (GAD-7)

    This tool is used to screen for generalized anxiety disorder and measure the severity of general anxiety levels. It consists of 7 questions. Participants are asked how often they have experienced anxiety symptoms over the past two weeks. The scoring for each item is as follows: 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day. The total score ranges from 0 to 21, with the following interpretations: 0-4 = Minimal anxiety, 5-9 = Mild anxiety, 10-14 = Moderate anxiety, and 15-21 = Severe anxiety (Konkan et al., 2013).

    Time frame: Each participant in the group will be evaluated twice. The first assessment will be conducted at the very beginning of the study before any intervention, and the second assessment will be performed after the interventions have been completed.

  8. Patient Health Questionnaire-15 (PHQ-15)

    Used to assess the frequency and severity of somatic (physical) symptoms and commonly applied for screening somatization disorder. Participants are asked how often they have experienced these symptoms over the past 4 weeks. The questionnaire includes 15 common physical symptoms (e.g., headache, stomach problems, fatigue, sleep disturbances). Each item is scored as 0 = Not at all, 1 = A little, and 2 = A lot. The total score ranges from 0 to 30, with the following interpretations: 0-4 = Low somatic symptom severity, 5-9 = Mild, 10-14 = Moderate, and 15 or higher = Severe somatic symptoms.

    Time frame: Each participant in the group will be evaluated twice. The first assessment will be conducted at the very beginning of the study before any intervention, and the second assessment will be performed after the interventions have been completed.

  9. Pittsburgh Sleep Quality Index (PSQI)

    Participants' sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The questionnaire consists of 24 items: 19 self-reported questions addressing factors related to sleep quality, and 5 items answered by a spouse or roommate. The 5 spouse/roommate items are clinically evaluated but not included in scoring. The 19 self-report items measure seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Each question is scored from 0 to 3. The total PSQI score (ranging from 0 to 21) is calculated by summing the seven component scores. A total score of 5 or below indicates good sleep quality, while a score above 5 indicates poor sleep quality (Ağargün, Kara, \& Anlar, 1996).

    Time frame: Each participant in the group will be evaluated twice. The first assessment will be conducted at the very beginning of the study before any intervention, and the second assessment will be performed after the interventions have been completed.

07

Study locations

1 site
  • Hatay Mustafa Kemal University, Faculty of Health Sciences, Physiotherapy and Rehabilitation Department
    Antakya, Hatay 31000, Turkey (Türkiye)
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in Oct 2025, 3 months.

Of 244 non-industry interventional studies with no phase under Temporomandibular Joint Disorders, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 21. This study's 3 months is below that.

Counting every sponsor, half of 248 studies reached it within 11 months; a quarter within 5 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 26, 2025
First posted
Jan 15, 2026
StartActual
Jul 17, 2025
Primary completionActual
Oct 17, 2025
CompletionEst.
Jul 15, 2026
Last update
Jul 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07345351
Lead sponsor
Mustafa Kemal University
Responsible party
Yasemin KARAASLAN (Principal Researcher, Head of Physiotherapy and Rehabilitation Department, Hatay Mustafa Kemal University, Mustafa Kemal University) — Principal investigator
First posted
Jan 15, 2026
Start date
Jul 17, 2025
Primary completion
Oct 17, 2025
Completion
Jul 15, 2026 (estimated)
Last update
Jul 1, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion